Vitamin D status in children and adults in Sweden: dietary intake and 25-hydroxyvitamin D concentrations in children aged 10–12 years and adults aged 18–80 years

Autor: Cecilia Nälsén, Wulf Becker, Monika Pearson, Peter Ridefelt, Anna Karin Lindroos, Natalia Kotova, Irene Mattisson

Publikováno v: Journal of Nutritional Science, Vol 9 (2020)

The study aimed to estimate vitamin D intake and plasma/serum 25-hydroxyvitamin D (25(OH)D) concentrations, investigate determinants of 25(OH)D concentrations and compare two 25(OH)D assays. We conducted two nationwide cross-sectional studies in Swed

Externí odkaz: https://doaj.org/article/83d3ed09eacb4ab3bed126741a0b888e

Cystatin C Predicts Incident Cardiovascular Disease in Twins

Autor: Johannes Arpegård, Patrik K. E. Magnusson, Xu Chen, Peter Ridefelt, Nancy L. Pedersen, Ulf De Faire, Per Svensson

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 6 (2016)

BackgroundCystatin C is associated with both renal function and atherosclerotic cardiovascular disease (ASCVD). We have previously shown a genetic correlation between cystatin C and prevalent ASCVD. The objective of this article is to study whether v

Externí odkaz: https://doaj.org/article/228251dfc54e4089a75ca58ff16659b9

Interlaboratory variation for NT-proBNP among Swedish laboratories in an external quality program 2011–2021

Autor: Morgan Lundgren, Peter Ridefelt, Mathias Karlsson, Anna Norling, Anders Larsson

Publikováno v: Clinical Chemistry and Laboratory Medicine (CCLM).

Objectives NT-proBNP is frequently used for ruling out heart failure. Different cut-offs are used depending on the clinical context, e.g. an acute or chronic condition. Medical decision limits have been suggested at 125 and 300 ng/L or 400 ng/L in in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed7f5f38760528448996d7d0c6b9391f
https://doi.org/10.1515/cclm-2023-0051

The complexity of kidney disease and diagnosing it - Cystatin C, selective glomerular hypofiltration syndromes and proteome regulation

Autor: Linnea Malmgren, Carl Öberg, Emil den Bakker, Felicia Leion, Joanna Siódmiak, Anna Åkesson, Veronica Lindström, Erik Herou, Alain Dardashti, Liana Xhakollari, Gabriel Grubb, Helena Strevens, Magnus Abrahamson, Johanna Helmersson‐Karlqvist, Martin Magnusson, Jonas Björk, Ulf Nyman, Johan Ärnlöv, Peter Ridefelt, Torbjörn Åkerfeldt, Magnus Hansson, Anna Sjöström, Johan Mårtensson, Yoshihisa Itoh, David Grubb, Olav Tenstad, Lars‐Olov Hansson, Isleifur Olafsson, Araceli Jarquin Campos, Martin Risch, Lorenz Risch, Anders Larsson, Gunnar Nordin, Hans Pottel, Anders Christensson, Henrik Bjursten, Arend Bökenkamp, Anders Grubb

Publikováno v: Malmgren, L, Öberg, C, den Bakker, E, Leion, F, Siódmiak, J, Åkesson, A, Lindström, V, Herou, E, Dardashti, A, Xhakollari, L, Grubb, G, Strevens, H, Abrahamson, M, Helmersson-Karlqvist, J, Magnusson, M, Björk, J, Nyman, U, Ärnlöv, J, Ridefeldt, P, Åkerfeldt, T, Hansson, M, Sjöström, A, Mårtensson, J, Itoh, Y, Grubb, D, Tenstad, O, Hansson, L-O, Olafsson, I, Campos, A J, Risch, M, Risch, L, Larsson, A, Nordin, G, Pottel, H, Christensson, A, Bjursten, H, Bökenkamp, A & Grubb, A 2022, ' The complexity of kidney disease and diagnosing it – cystatin C, selective glomerular hypofiltration syndromes and proteome regulation ', Journal of Internal Medicine . https://doi.org/10.1111/joim.13589
Journal of Internal Medicine

Estimation of kidney function is often part of daily clinical practice, mostly done by using the endogenous GFR-markers creatinine or cystatin C. A recommendation to use both markers in parallel in 2010 has resulted in new knowledge concerning the pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d2fddf739bead5c1d6351feaf11950

Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

Autor: Emil Hagström, Anders Larsson, Torbjörn Åkerfeldt, Peter Ridefelt, Maria Svensson

Publikováno v: Scandinavian Journal of Clinical and Laboratory Investigation. 79:39-42

OBJECTIVES: Non-HDL-cholesterol (non-HDL-C) has been reported to be a better marker of cardiovascular risk than LDL-cholesterol (LDL-C) especially in individuals with high triglyceride values. Further, levels of remnant cholesterol have been suggeste

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::784dff2cc8285fff60fce4e652f9ae82
https://doi.org/10.1080/00365513.2018.1550809